1Lin Cai~1 Shun-Zhang Yu~2 Zuo-Feng Zhang~3 1 Department of Epidemiology,Fujian Medical University,Fuzhou 350004,Fujian Province,China2 Department of Epidemiology,Shanghai Medical University,Shanghai 200032,China3 Department of Epidemiology,UCLA School of Public Health,Los Angeles California,USA.Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle,Fujian Province[J].World Journal of Gastroenterology,2001,7(6):792-795. 被引量：26
6Van Aken E, De Wever O, Correia da Rocha A S, et al. Defective E-cadherin/catenin complexes in human cancer [ J ]. Virchows Arch,2001,439(6) :725 -751.
7Cattaneo F, Venesio T, Molatore S,et al. Functional analysis and case-control study of-160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk [ J]. Anticancer Res, 2006,26(6B) :4627 -4632.
8Wang G Y,Lu C Q,Zhang R M,et al. The E-cadherin gene polymorphism 160C - > A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies[ J ]. Am J Epidemiol,2008,167 (1):7-14.
9Grunhage F, Jungck M, Lamberti C, et al. Association of familial colorectal cancer with variants in the E-cadherin ( CDH1 ) and cyclin D1 (CCND1) genes[J]. Int J Colorectal Dis,2008,23(2) : 147 - 154.
10Kotsinas A, Evangelou K, Sideridou M,et al. The 3' UTR IGF2R- A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer [ J ]. Cancer Lett, 2008,259(2) :177 - 185.
